相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population
Mayur M. Amonkar et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Gene Amplification and Protein Overexpression of EGFR and ERBB2 in Sinonasal Squamous Cell Carcinoma
Fernando Lopez et al.
CANCER (2012)
PTEN as a Prognostic and Predictive Marker in Postoperative Radiotherapy for Squamous Cell Cancer of the Head and Neck
Miroslaw Snietura et al.
PLOS ONE (2012)
TISSUE MICROARRAY EVIDENCE OF ASSOCIATION BETWEEN p16 AND PHOSPHORYLATED eIF4E IN TONSILLAR SQUAMOUS CELL CARCINOMA
Matthew G. Fury et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors
Filip Janku et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers
Luc G. T. Morri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Nishant Agrawal et al.
SCIENCE (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
The molecular biology of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2011)
The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer
W. J. Pattje et al.
BRITISH JOURNAL OF CANCER (2010)
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
Dora Dias-Santagata et al.
EMBO MOLECULAR MEDICINE (2010)
AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma
Yoram Cohen et al.
GYNECOLOGIC ONCOLOGY (2010)
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
James A. Bonner et al.
LANCET ONCOLOGY (2010)
Profile of TP53 gene mutations in sinonasal cancer
Reetta Holmila et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung
Donatella Malanga et al.
CELL CYCLE (2008)
An activating mutation in AKT1 in human prostate cancer
Joost L. Boormans et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer
Johan Bussink et al.
LANCET ONCOLOGY (2008)
A transforming mutation in the pleckstrin homology domain of AKT1 in cancer
John D. Carpten et al.
NATURE (2007)
Phosphorylation of akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer
Ziwei Yu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
PIK3CA mutations in head and neck squamous cell carcinoma
WL Qiu et al.
CLINICAL CANCER RESEARCH (2006)
Expression of protein tyrosine kinases in head and neck squamous cell carcinomas
WM Ongkeko et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Frequent genetic and biochemical alterations of the PI3-K/AKT/PTEN pathway in head and neck squamous cell carcinoma
JMG Pedrero et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01
P Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2004)
分享论文
